Saturday 17 October 2026
Export LNSR’s income statement to Excel — free account
LENSAR, Inc.
LNSR Healthcare Medical Devices
LENSAR, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $58.4 million, up 9.24% from fiscal 2024. In the quarter to June 2026, revenue grew 18.4%, EPS grew 291.7% and free cash flow grew 96.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
5.80
0.23
−3.81%
Follow LNSR
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 3 | 5 | 4 | 4 | 5 | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/S ratio |
2.38 | 1.92 | 1.05 | 0.78 | 1.63 | 1.27 | 2.53 | 2.53 | — |
Altman Z-Score |
(2.84) | (1.26) | (0.99) | (1.22) | 1.47 | 0.98 | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Altman Z″-Score (non-manufacturers) |
(10.13) | (5.37) | (2.17) | (2.32) | 2.74 | 6.10 | (4.79) | (4.33) | — |
P/Operating CF |
225.03 | 28.16 | (92.34) | (5.83) | (75.98) | (16.78) | (1,221.55) | (1,221.55) | — |
Beneish M-Score |
(4.30) | (4.13) | (2.94) | (2.80) | (2.17) | (3.34) | (2.95) | — | — |
P/B ratio |
0.00 | 21.18 | 1.33 | 0.66 | 1.02 | 0.50 | 0.97 | 0.97 | — |
Price to Tangible BV |
0.00 | 0.00 | 1.98 | 0.93 | 1.28 | 0.61 | 1.19 | 1.19 | — |
EV/Sales |
2.18 | 1.62 | 0.63 | 0.55 | 0.89 | (0.03) | 1.16 | 1.16 | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 | 0.00 | — |
EV/Operating CF |
(8.59) | (38.17) | (2.75) | (1.30) | (3.44) | 0.06 | (1.66) | (1.66) | — |
EV/FCF |
(8.54) | (35.72) | (2.69) | (1.29) | (3.31) | 0.06 | (1.63) | (1.63) | — |
Quick Ratio |
0.60 | 1.90 | 2.41 | 1.81 | 4.16 | 5.03 | 1.02 | 0.87 | — |
Current Ratio |
1.15 | 2.80 | 3.99 | 2.95 | 5.14 | 6.90 | 2.19 | 1.53 | — |
Net Debt/EBITDA |
0.89 | 3.22 | 2.76 | 0.88 | 1.87 | 2.55 | (1.76) | (0.63) | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 58.49% | 21.88% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.66) | (0.31) | — |
Asset Turnover |
0.85 | 0.79 | 0.67 | 0.58 | 0.47 | 0.46 | 0.96 | 1.69 | — |
Operating CF/Net income |
0.43 | 0.07 | 0.67 | 0.75 | 0.46 | 0.70 | 0.86 | 0.13 | — |
Capex/Depreciation |
(0.02) | (0.04) | (0.07) | (0.03) | (0.13) | (0.13) | (0.54) | (0.71) | — |
Interest Coverage |
— | — | — | (1,186.88) | — | (13.81) | (6.35) | (2.81) | — |
| 324.05% | (164.03%) | (38.14%) | (41.12%) | (32.11%) | (107.89%) | 57.46% | 55.06% | — | |
| (49.78%) | (46.22%) | (22.93%) | (32.56%) | (26.93%) | (34.80%) | (46.22%) | (97.24%) | — | |
ROIC |
0.00% | 0.00% | (81.61%) | (46.18%) | (52.85%) | (43.45%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
(511.49%) | (113.62%) | (40.53%) | (87.12%) | (53.18%) | (38.96%) | (145.49%) | (293.44%) | — |
Average Days of Receivables |
39.83 | 41.52 | 34.64 | 62.35 | 49.13 | 27.84 | 40.46 | 49.42 | — |
Research and Development Expense of Revenue |
9.62% | 9.96% | 14.56% | 33.41% | 35.86% | 28.63% | 24.79% | 11.42% | — |
Selling, General and Administrative Expense of Revenue |
77.28% | 49.52% | 61.90% | 76.84% | 69.32% | 90.09% | 56.17% | 66.19% | — |
Intangible Assets out of Total Assets |
0.07 | 0.09 | 0.16 | 0.22 | 0.16 | 0.15 | 0.39 | 0.43 | 0.00 |
Share Based Compensation of Revenue |
5.38% | 4.98% | 13.14% | 18.70% | 19.93% | 34.28% | 0.33% | 0.50% | — |
Graham Net Nets |
(0.36) | (0.19) | 0.23 | 0.72 | 0.59 | 1.39 | 0.72 | 0.72 | — |
Graham Number |
11.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
(24.94%) | (30.43%) | (32.89%) | (72.16%) | (34.89%) | (125.07%) | (94.64%) | (94.64%) | — |
Free Cash Flow Yield |
(10.72%) | (2.36%) | (22.32%) | (53.98%) | (16.60%) | (42.14%) | (28.07%) | (28.07%) | — |
Revenue per Share |
4.89 | 4.64 | 3.84 | 3.48 | 3.68 | 5.71 | 28.53 | 22.79 | — |
Operating CF per Share |
(1.24) | (0.20) | (0.88) | (1.46) | (0.96) | (2.98) | (11.77) | (1.76) | — |
Capex per Share |
(0.01) | (0.01) | (0.02) | (0.01) | (0.04) | (0.07) | (1.95) | (3.04) | — |
Free Cash Flow per Share |
(1.25) | (0.21) | (0.90) | (1.47) | (0.99) | (3.05) | (13.72) | (4.80) | — |
Cash per Share |
1.50 | 1.95 | 2.19 | 1.44 | 3.38 | 8.79 | 4.31 | 3.13 | — |
Shareholders Equity per Share |
(2.18) | 0.42 | 3.05 | 4.13 | 5.85 | 14.54 | (28.55) | (19.13) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
(2.18) | 0.42 | 3.05 | 4.13 | 5.85 | 14.54 | (28.55) | (19.13) | — |
Free Cash Flow |
(14.91) | (2.43) | (9.89) | (14.97) | (9.32) | (14.12) | (14.68) | (5.13) | — |
Working Capital |
6.20 | 26.98 | 34.81 | 22.30 | 36.10 | 49.92 | 9.35 | 4.09 | — |
Capital Expenditures |
(0.08) | (0.16) | (0.24) | (0.11) | (0.35) | (0.33) | (2.09) | (3.25) | — |
Net Current Asset Value |
(50.68) | (19.46) | 10.29 | 19.86 | 33.23 | 46.48 | (47.91) | (37.60) | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 | — |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.07 | 0.13 | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
8.56 | 5.54 | 5.16 | 6.05 | 3.66 | 3.08 | 5.37 | 6.57 | — |
Cash ROIC |
185.47% | (8.90%) | (17.21%) | (26.42%) | (10.78%) | (13.09%) | 255.80% | 47.53% | — |
Accounts Receivable Turnover |
9.38 | 10.61 | 8.40 | 6.62 | 10.36 | 9.78 | 9.13 | 6.37 | — |
Accounts Payable Turnover |
2.51 | 5.53 | 4.47 | 3.80 | 6.43 | 6.07 | 11.58 | 9.13 | — |
Inventory Turnover |
1.90 | 2.04 | 1.54 | 1.69 | 1.67 | 1.14 | 2.85 | 2.25 | — |
Average Days of Payables |
221.26 | 79.16 | 69.46 | 128.48 | 59.14 | 73.58 | 33.27 | 37.78 | — |
Days of Inventory on Hand |
250.85 | 150.90 | 271.95 | 278.20 | 142.43 | 399.58 | 170.15 | 108.70 | — |
Average Receivables |
6.23 | 5.04 | 5.02 | 5.34 | 3.33 | 2.70 | 3.34 | 3.83 | — |
Average Payables |
12.49 | 5.00 | 4.71 | 4.06 | 2.59 | 2.03 | 1.49 | 1.49 | — |
Average Inventory |
16.47 | 13.56 | 13.71 | 9.11 | 9.98 | 10.77 | 6.06 | 6.06 | — |
Average Assets |
68.86 | 67.94 | 62.71 | 61.15 | 72.79 | 56.83 | 31.71 | 14.44 | — |
Average Common Equity |
(10.58) | 19.15 | 37.71 | 48.43 | 61.04 | 18.33 | (25.51) | (25.51) | — |
Columns are period end dates